Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication

Authors: Rabello-Fonseca, RM; Azulay, DR1; Luiz, RR2; Mandarim-de-Lacerda, CA3; Cuzzi, T4; Manela-Azulay, M1

Source: Journal of the European Academy of Dermatology & Venereology, Volume 23, Number 2, February 2009 , pp. 115-123(9)

Publisher: Blackwell Publishing

Purchase options

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$47.44 plus tax      Refund Policy

OR

 
More like this?
Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial

Abstract:

Background 

Despite evidences of the beneficial clinical effects of oral isotretinoin in the treatment of cutaneous photoaging, scientific evidences are still scarce, mainly supported by histopathological and morphometric studies. Objectives 

To analyse possible clinical and morphological changes resulting from the treatment of photoaging with oral isotretinoin. Methods 

Thirty female patients, aged 40 to 55 years, phototypes II to IV, with moderate to severe photoaging were randomly assigned to two groups of 15 each. Group I (G I) patients were treated with 10 mg of isotretinoin and group II (G II) with 20 mg of oral isotretinoin thrice a week for 3 months. Skin biopsies were performed before and after the end of therapy, and the various sections were submitted to specific staining for collagen and elastic fibres. To analyse the changes, morphometric studies were performed, and the results obtained were analysed by Student's t-test (paired and non-paired). Clinical results of therapy regarding texture, colouring and aspect of the wrinkles were assessed by both physician and patient. Results 

The increase in the amount of collagen fibres was statistically significant with both dosage regimens (mean, 37.8%, increasing to 44.4%; P = 0.029 with the 10-mg dosage; and mean, 36.6%, increasing to 41.9%; P = 0.01 with the 20-mg dosage). A pattern pointing toward a decrease in the number of elastic fibres was found (mean, 15.3-12%; P = 0.014 with the 10-mg dosage; mean, 15.5-14%; P = 0.125 with the 20-mg dosage). Additionally, there was improvement in the general aspect of the skin, regarding texture, wrinkles depth and skin coloration. Limitations 

Despite ethical considerations, a lack of a control group using placebo may render the results less accurate. Conclusion 

Low dosages of oral isotretinoin seem to be an effective therapeutic option for cutaneous photoaging. Conflicts of interest

None declared

Keywords: aging skin; morphometry; oral isotretinoin; photoaging

Document Type: Research article

DOI: 10.1111/j.1468-3083.2008.02947.x

Affiliations: 1: Department of Dermatology, Federal University of Rio de Janeiro, Brazil 2: Institute of Public Health Studies, Federal University of Rio de Janeiro, Brazil 3: Laboratory of Morphometry, University of the State of Rio De Janeiro, Brazil 4: Department of Pathology, Federal University of Rio de Janeiro, Brazil

Back to top

Content Key:
Free Content - Free
New Content - New
Open Access Content - Open Access
Subscribed Content - Subscribed
Free Trial Content - Free Trial
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in
Need to register?
Sign up here
Text size: A | A | A | A